2 of the best ASX 50 shares to buy in April

Although the S&P/ASX 50 index may not be as well-known as the S&P/ASX 200 Index (ASX: XJO), it is arguably just as important.

This illustrious index is home to 50 of the largest companies on the Australian share market. These include household names and companies that are regarded as true blue chip shares.

Not all shares on the index are necessarily in the buy zone, but two that come highly rated are listed below:

The first ASX 50 share to consider is CSL. This leading biotechnology company manufactures and develops a portfolio of leading therapies and vaccines. This includes flu vaccines, immunoglobulins, and countless other plasma-based products. It also operates one of the most wide-reaching plasma collection networks.

While…